Quest Diagnostics Employer Solutions’ Post

Key Takeaways from the 2024 Drug Testing Survey - Discover the latest industry trends from Wondfo USA and Current Consulting Group! Download our article here to learn more: https://hubs.la/Q02Bcj-40 #SAFElife #WondfoUSA #DrugTestSurvey

Many companies want to optimize their drug substance production, but they worry about contamination and product loss. When you’re looking for a CMDO, here are four strategies to maximize drug substance utilization: https://bit.ly/3WNAhhP #pharmamfg #contractmfg

Many companies want to optimize their drug substance production, but they worry about contamination and product loss. When you’re looking for a CMDO, here are four strategies to maximize drug substance utilization: https://bit.ly/3Xu5nvN #pharmamfg #contractmfg

Many companies want to optimize their drug substance production, but they worry about contamination and product loss. When you’re looking for a CMDO, here are four strategies to maximize drug substance utilization: https://bit.ly/4dmRzaS #pharmamfg #contractmfg

Many companies want to optimize their drug substance production, but they worry about contamination and product loss. When you’re looking for a CMDO, here are four strategies to maximize drug substance utilization: https://bit.ly/3AhPizU #pharmamfg #contractmfg

Many companies want to optimize their drug substance production, but they worry about contamination and product loss. When you’re looking for a CMDO, here are four strategies to maximize drug substance utilization: https://bit.ly/3ybxhlS #pharmamfg #contractmfg

Many companies want to optimize their drug substance production, but they worry about contamination and product loss. When you’re looking for a CMDO, here are four strategies to maximize drug substance utilization: https://bit.ly/3Yuf3Xd #pharmamfg #contractmfg

Relying on existing data, the 505(b)(2) pathway can streamline the drug approval process, bringing modified versions of existing drugs to market faster and at a lower cost. Is it right for you? Find out: https://bit.ly/3z2jSdB #FDAApprovals #DrugDevelopment #ClinicalTrials

New FDA guidance on correspondence related to generic drug is available today This guidance provides information regarding the process by which generic drug manufacturers and related industry can submit controlled correspondence to FDA requesting information related to generic drug development and the Agency’s process for providing communications related to such correspondence. This guidance also describes the process by which generic drug manufacturers and related industry can submit requests to clarify ambiguities in FDA’s controlled correspondence response and the Agency’s process for responding to those requests.

Register now for part 3 of our 8-part storage and stability webinar series: Photostability, Transport Stress, and In-Use Studies for Drug Products 👉 https://lnkd.in/efe5cE3i 📅 15th October 2024 | 3-4pm CEST Our experts Claire Roubaud Sambuq and Alissa ESTEVEZ will be discussing how photostability testing (ICH Q1B) assesses the impact of light exposure on drug substances and products, while transport stress and in-use studies evaluate the effects of shipping conditions and product handling after opening, respectively. During the webinar we will discuss: ◾Photostability ICHQ1B and forced degradation ◾Transport Stress ◾In-use studies To sign up in advance for all webinars in this series, visit our webpage where you can find them all: https://lnkd.in/eJ53URjH #eurofins #testingforlfe #biopharma #stability #storage #webinar